Dataset Information

Mechanosensory PNECs drive airway inflammation via secretoneurin-Slc23a2

ABSTRACT: The respiratory epithelium is the body’s most exposed internal surface to airborne antigens and pathogens. Beyond serving as a physical barrier, epithelial cells actively work to expel threats by secreting mucus and cough-mediated pressure dynamics and orchestrating an immune response1. However, the mechanisms by which epithelial cells transduce mechanical changes in the airway during allergic immune activation remain unclear. We demonstrated that pulmonary endocrine cells (PNECs), a specialized rare cell population, sense airway pressure fluctuations via the mechanosensitive ion channel Piezo2 and promote eosinophilic inflammation by secreting secretoneurin, a chromogranin family neuropeptide. Piezo2-expressing PNECs form clusters at bronchial bifurcation sites, and their anatomical locations tend to experience maximal mechanical stress2. PNECs actively secrete secretoneurin in response to positive pressure ventilation in vivo. Intratracheal administration of secretoneurin induces massive infiltration of eosinophils and eosinophil extracellular trap cell death (EETosis), a pathological process central to airway inflammation3. In a murine model of Aspergillus-induced severe asthma, conditional deletion of Piezo2 or secretoneurin-encoding Scg2 specifically in PNECs, significantly ameliorated eosinophilic inflammation in the lungs. Unbiased proteoliposome screening identified sodium-dependent ascorbate transporter SLC23A2 as a binding partner of secretoneurin in eosinophils. In human respiratory tissues, a spatial transcriptome analysis and immunohistochemistry confirmed the expression of both PIEZO2 and SCG2 in PNECs. Furthermore, patients with lung eosinophilic inflammation showed significantly higher secretoneurin concentrations in bronchoalveolar lavage fluid than other patients. These results revealed a previously unrecognized epithelial mechanosensory pathway that drives eosinophilic inflammation via the PIEZO2-secretoneurin-SLC23A2-EETosis axis, thereby providing potential therapeutic targets for eosinophilic airway diseases.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE304603 | GEO | 2025/08/16

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Memory helper T cells provide long-lasting host defeMemory helper T cells provide long-lasting host defense against microbial pathogens, while distinct subpopulations of memory T cells drive chronic inflammatory diseases such as asthma. Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. The immunological mechanisms that induce airway fibrotic changes in allergic inflammation remain unknown. We found that Interleukin-33 (IL-33) enhanced Amphiregulin production by the IL-33 receptor, ST2hi memory T helper-2 (Th2) cells. Amphiregulin-epidermal growth factor receptor (EGFR)-mediated signaling directly reprogramed eosinophils to an inflammatory state with enhanced production of Osteopontin, a key profibrotic immunomodulatory protein. IL-5-producing memory Th2 cells and Amphiregulin-producing memory Th2 cells appeared to cooperate to establish lung fibrosis. The analysis of polyps from patients with eosinophilic chronic rhinosinusitis revealed fibrosis with accumulation of Amphiregulin-producing CRTH2hiCD161hiCD45RO+CD4+ Th2 cells and Osteopontin-producing eosinophils. Thus, the IL-33-Amphiregulin-Osteopontin axis directs fibrotic responses in eosinophilic airway inflammation and is a potential target for the treatment of fibrosis induced by chronic allergic disorders. against microbial pathogens, while distinct subpopulations of memory T cells drive chronic inflammatory diseases such as asthma. Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. The immunological mechanisms that induce airway fibrotic changes in allergic inflammation remain unknown. We found that Interleukin-33 (IL-33) enhanced Amphiregulin production by the IL-33 receptor, ST2 hi memory T helper-2 (Th2) cells. Amphiregulin-epidermal growth factor receptor (EGFR)-mediated signaling directly reprogramed eosinophils to an inflammatory state with enhanced production of Osteopontin, a key profibrotic immunomodulatory protein. IL-5-producing memory Th2 cells and Amphiregulin-producing memory Th2 cells appeared to cooperate to establish lung fibrosis. The analysis of polyps from patients with eosinophilic chronic rhinosinusitis revealed fibrosis with accumulation of Amphiregulin-producing CRTH2hiCD161hiCD45RO+CD4+ Th2 cells and Osteopontin-producing eosinophils. Thus, the IL-33-Amphiregulin-Osteopontin axis directs fibrotic responses in eosinophilic airway inflammation and is a potential target for the treatment of fibrosis induced by chronic allergic disorders.

Project description:Allergic airway inflammation is a chronic inflammatory condition resulting from uncontrolled immune responses to environmental antigens. While it is well-established that allergic immune responses exhibit a high degree of diversity, driven by primary effector cell types like eosinophils, neutrophils, or CD4 T cells with distinct effector signatures, the exact mechanisms responsible for such pathogenesis remain largely elusive. Foxp3+ regulatory T cells (Treg) is an indispensable immune regulator during chronic inflammation including allergic airway inflammation. Emerging evidence suggests that Tregs infiltrating inflamed tissues exhibit distinct phenotypes dependent on the specific tissue sites and can display significant heterogeneity and tissue residency. Whether diverse allergic inflammatory responses in the lung influences infiltrating Treg heterogeneity or Treg lung residency has not previously been explored. We employed an unbiased single-cell RNAseq approach to study lung-infiltrating Tregs in models of eosinophilic and neutrophilic airway inflammation models, in which Tregs are critical immune regulators of inflammation. We found that lung-infiltrating Tregs are highly heterogeneous and that Tregs displaying lung residency phenotypes are significantly different depending on the types of inflammation. Tregs expression of ST2, a receptor for alarmin cytokine IL-33, was predominantly induced by eosinophilic inflammation and by tissue residency. However, Treg-specific ST2 deficiency did not affect the development of eosinophilic allergic inflammation nor the generation of lung resident Tregs. These results uncover a striking heterogeneity among Tregs infiltrating the lungs during allergic airway inflammation. The results also indicate that varying types of inflammation may give rise to phenotypically distinct lung resident Tregs. Thus, the present study underscores a novel mechanism by which inflammatory environments may shape the composition of infiltrating Tregs, allowing them to regulate inflammatory responses through tissue-adapted mechanisms.

Dataset Information

Mechanosensory PNECs drive airway inflammation via secretoneurin-Slc23a2

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets